Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort

BACKGROUND: Patients with paroxysmal nocturnal hemoglobinuria (PNH) often have concurrent aplastic anemia (AA). This study aimed to determine whether eculizumab-treated patients show clinical benefit regardless of concurrent AA. METHODS: We analyzed 46 PNH patients ≥18 years of age who were diagnose...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Res
Egile Nagusiak: Choi, Chul Won, Jang, Jun Ho, Kim, Jin Seok, Jo, Deog-Yeon, Lee, Je-Hwan, Kim, Sung-Hyun, Kim, Yeo-Kyeoung, Won, Jong-Ho, Chung, Joo Seop, Kim, Hawk, Lee, Jae Hoon, Kim, Min Kyoung, Eom, Hyeon-Seok, Hyun, Shin Young, Kim, Jeong-A, Lee, Jong Wook
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5641513/
https://ncbi.nlm.nih.gov/pubmed/29043236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2017.52.3.207
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak